About: Sinergistic therapeutic efffect of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin leads to significantly prolonged survival of mice

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Sinergistic therapeutic efffect of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin leads to significantly prolonged survival of mice Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description	Sinergistic therapeutic efffect of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin leads to significantly prolonged survival of mice Naším cílem bylo blíže objasnit mechanismus účinku imunokomplexů IL-2/anti-IL-2 protilátky a zhodnotit jejich in vivo potenciál v kombinaci s polymerním doxorubicinovým konjugátem na buněčné linii B16F10 melanomu (cs) Sinergistic therapeutic efffect of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin leads to significantly prolonged survival of mice (en)
Title	Sinergistic therapeutic efffect of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin leads to significantly prolonged survival of mice Sinergistic therapeutic efffect of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin leads to significantly prolonged survival of mice (en) Součinný léčebný efekt imunokomplexů IL-2/anti-IL-2 protilátky a (cs)
skos:prefLabel	Sinergistic therapeutic efffect of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin leads to significantly prolonged survival of mice Sinergistic therapeutic efffect of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin leads to significantly prolonged survival of mice (en) Součinný léčebný efekt imunokomplexů IL-2/anti-IL-2 protilátky a (cs)
skos:notation	RIV/61388971:_____/08:00325250!RIV09-AV0-61388971
http://linked.open...avai/riv/aktivita	P Z
http://linked.open...avai/riv/aktivity	P(1M0505), P(GP301/07/P192), Z(AV0Z40500505), Z(AV0Z50200510)
http://linked.open...vai/riv/dodaniDat	2009
http://linked.open...aciTvurceVysledku	Říhová, Blanka Chmelová, Helena Kovář, Marek Tomala, Jakub
http://linked.open.../riv/druhVysledku	D - Článek ve sborníku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Mikrobiologický ústav AV ČR, v. v. i.
http://linked.open...dnocenehoVysledku	394953
http://linked.open...ai/riv/idVysledku	RIV/61388971:_____/08:00325250
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	doxorubicin; IL-2/anti-IL-2mAb; melanoma (en)
http://linked.open.../riv/klicoveSlovo	doxorubicin melanoma IL-2/anti-IL-2mAb
http://linked.open...ontrolniKodProRIV	[EF86896A6C8F]
http://linked.open...v/mistoKonaniAkce	Tokyo
http://linked.open...i/riv/mistoVydani	Basel
http://linked.open...i/riv/nazevZdroje	Meeting of the International Society of Oncology and BioMarkers /36./
http://linked.open...in/vavai/riv/obor	EC
http://linked.open...ichTvurcuVysledku	4 (xsd:int)
http://linked.open...cetTvurcuVysledku	6 (xsd:int)
http://linked.open...vavai/riv/projekt	Potentiation of anti-tumor immunity with cytokine immnocomplexes during treatment with polymer-bound drugs Center of targeted therapeutic drugs
http://linked.open...UplatneniVysledku	2008
http://linked.open...iv/tvurceVysledku	Chmelová, Helena Kovář, Marek Strohalm, Jiří Tomala, Jakub Ulbrich, Karel Říhová, Blanka
http://linked.open...vavai/riv/typAkce	WRD - Světová
http://linked.open...ain/vavai/riv/wos	000259724800097
http://linked.open.../riv/zahajeniAkce	2008-10-05 (xsd:date)
http://linked.open...n/vavai/riv/zamer	Progresivní makromolekulární materiály a supramolekulární systémy: syntéza a studium vlastností, jevů a možností využití pro speciální aplikace a moderní technologie Microorganisms in Research and Biotechnology
issn	1010-4283
number of pages	1 (xsd:int)
http://purl.org/ne...btex#hasPublisher	KARGER
is http://linked.open...avai/riv/vysledek of	Sinergistic therapeutic efffect of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin leads to significantly prolonged survival of mice Sinergistic therapeutic efffect of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin leads to significantly prolonged survival of mice Sinergistic therapeutic efffect of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin leads to significantly prolonged survival of mice Sinergistic therapeutic efffect of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin leads to significantly prolonged survival of mice

Faceted Search & Find service v1.16.116 as of Feb 22 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of Feb 22 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 82 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software